Assessment of cardiac involvements in rheumatic diseases : Detecting cardiac magnetic resonance imaging and inflammatory biomarker approach

Assessment of cardiac involvements in rheumatic diseases : Detecting cardiac magnetic resonance imaging and inflammatory biomarker approach - Assessment of cardiac involvements in rheumatic diseases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022503

Enrollment

132

Registered

2016-05-27

Start date

2016-02-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatic disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient, diagnosed with rheumatic disease, without cardiac lesions

Exclusion criteria

Exclusion criteria: Participants were excluded if they had prior self-reported, physician-diagnosed cardiovascular events or procedures, such as myocardial infarction, angioplasty, and congestive heart failure. Diabetes(HbA1c > 6.1 %), hypertension(systolic blood pressure > 140 mmHg and/or diastolic blood pressure > 90 mmHg), dyslipidemia(LDL cholesterol levels > 140 mg/dL, HDL cholesterol levels < 40 mg/dL, triglyceride levels > 150 mg/dL) were excluded. Furthermore, exclusions were patients who were contraindicated of MRI contrast agent, and who couldn't examine MRI e.g. people containing the cardiac pace maker and so on.

Design outcomes

Primary

Measure	Time frame
We explore the association of cardiac MRI abnormalities with rheumatic disease activity and severity measures.	—

Secondary

Measure	Time frame
Association of cardiac involvement, detecting by a cardiac MRI, with inflammatory biomarker	—

Countries

Japan

Contacts

Public ContactAkiko Hirama

Nihon University Itabashi Hospital rheumatology

kaita_sugiyama@yahoo.co.jp03-3972-8111

Outcome results